ALXN - ALEXION PHARMACEUTICALS INC
This page shows which of the focused investors we track hold ALXN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2017 it was held by 2 managers with an aggregate reported value of $206.93M, which is 0.03% of the combined portfolio.
As of Q2 2017, 2 tracked institutional managers held ALXN (ALEXION PHARMACEUTICALS INC) with an aggregate reported value of $206.93M — 0.03% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades ALXN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2017
- Ticker
- ALXN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Daniel Loeb - Third Point | 1.35% | New | 1,250,000 | $152.09M |
| 2 | Bill Miller - Miller Value Partners | 2.22% | Add +25.7% | 450,725 | $54.84M |
Loading holder history for ALXN…